Royalty Pharma (RPRX)

AI Score

Unlock

32.60

0.41 (1.27%)

At close: Apr 17, 2025, 3:59 PM

32.80

0.61%

After-hours: Apr 17, 2025, 06:20 PM EDT

Royalty Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	2.26B	2.27B	2.24B	2.24B	2.35B	2.32B	2.36B	2.36B	2.24B	2.25B	2.26B	2.28B	2.29B	2.28B	2.24B	2.19B	2.12B	2.01B	1.93B	1.88B	1.81B	1.36B	892.49M	434.88M
Cost of Revenue	591.25M	667.77M	943.25M	1.18B	713.68M	642.84M	670.76M	535.25M	422.12M	682.95M	383.69M	283.7M	283.7M	146.54M	146.54M	146.54M	228.88M	1.02B	1.14B	1.2B	1.16B	244.58M	122.24M	50.03M
Gross Profit	1.67B	1.6B	1.29B	1.06B	1.64B	1.68B	1.69B	1.82B	1.82B	1.56B	1.88B	1.99B	2.01B	2.14B	2.09B	2.05B	1.89B	989.6M	798.33M	678.53M	650.51M	1.11B	770.25M	384.85M
Operating Income	1.29B	1.54B	960.3M	939.51M	1.49B	974.59M	1.02B	994.16M	734.91M	792.99M	903.83M	1.42B	1.43B	1.59B	1.8B	1.46B	1.6B	2.61B	2.64B	2.55B	2.62B	1.29B	758.76M	430.9M
Interest Income	38.31M	44.81M	50.73M	63.01M	72.29M	109.64M	100.24M	85.51M	78.33M	45.12M	43.35M	46.47M	53.53M	64.11M	53.43M	42.12M	28.38M	10.42M	13.41M	15.16M	22.33M	19.08M	14.5M	10.03M
Pretax Income	1.33B	1.71B	1.03B	1.19B	1.7B	372.47M	470.81M	611.07M	230.06M	893.76M	895.15M	1.21B	1.24B	1.55B	1.96B	1.75B	1.7B	2.78B	2.6B	2.17B	2.46B	1.01B	574.86M	396.09M
Net Income	858.77M	1.15B	673.24M	798.86M	1.13B	30.32M	176.04M	252.92M	-127.71M	490.37M	374.46M	510.74M	619.73M	782.82M	971.89M	973.19M	975.31M	2.22B	2.34B	2.05B	2.35B	928.14M	519.16M	367.44M
Selling & General & Admin	237.08M	228.08M	228.59M	221.52M	249.56M	263.79M	257.25M	261.46M	227.3M	200.24M	198.13M	191.21M	182.83M	186.66M	189.08M	186.96M	181.86M	154.93M	129.53M	117.08M	103.44M	80.38M	54.77M	24.43M
Research & Development	2.5M	2.5M	52.5M	52.5M	52.5M	102M	77M	77.11M	177.11M	230.43M	295.43M	297.94M	200.08M	104.26M	18.76M	21.42M	26.41M	34.28M	52M	67.68M	83.04M	67.17M	44.45M	22.99M
Other Expenses	-860.63M	-946.63M	-720.74M	-507.22M	195.19M	427.04M	733.8M	838.43M	909.91M	596.25M	290.39M	184.57M	-5.68M	79.14M	210.94M	211.3M	205.34M	125.48M	-5.29M	-5.59M	393K	253K	21K	58K
Operating Expenses	971M	722M	1.28B	1.3B	862.23M	1.31B	1.31B	1.18B	1.31B	1.3B	1.21B	857.35M	858.75M	694.47M	439.74M	731.32M	527.03M	-605.4M	-701.62M	-673.46M	-808.92M	65.51M	133.73M	3.98M
Interest Expense	225.75M	206.75M	186.28M	184.21M	186.93M	186.89M	187.83M	187.85M	187.96M	187.98M	185.33M	175.79M	166.14M	157.17M	143.84M	140.6M	156.77M	182.12M	219.91M	254.89M	268.57M	205.23M	136.43M	67.27M
Selling & Marketing Expenses	292K	107K	107K	-185K	-185K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	971M	722M	1.28B	1.3B	862.23M	1.31B	1.31B	1.18B	1.31B	1.3B	1.21B	857.35M	858.75M	694.47M	439.74M	731.32M	527.03M	-605.4M	-701.62M	-673.46M	-808.92M	65.51M	133.73M	3.98M
Income Tax Expense	209.32M	306.32M	356.29M	387.62M	565.01M	342.15M	294.77M	358.15M	357.77M	404.61M	521.89M	700.78M	622.68M	44.33M	258.08M	52M	38.59M	648.78M	407.19M	335.33M	349.33M	270.52M	178.49M	90.44M
Shares Outstanding (Basic)	447.63M	447.63M	451.02M	448.62M	446.57M	448.44M	450.4M	445.61M	443.17M	607.23M	607.21M	607.2M	428.23M	428.23M	409.34M	389.76M	388.13M	370M	353.98M	350.55M	354.18M	354.18M	354.18M	354.18M
Shares Outstanding (Diluted)	592.73M	592.73M	596.91M	597.48M	446.57M	601.14M	605.86M	607.25M	443.17M	607.23M	607.21M	607.2M	607.17M	607.17M	607.16M	607.15M	388.13M	370M	353.98M	350.55M	354.18M	354.18M	354.18M	354.18M
EPS (Basic)	2.31	2.96	1.51	1.79	2.54	0.05	0.25	0.24	-0.59	0.81	0.69	1.27	1.52	1.94	2.49	2.66	2.68	6.25	6.61	5.79	6.63	2.62	1.47	1.04
EPS (Diluted)	1.80	2.56	1.51	1.78	2.53	0.04	0.24	0.24	-0.59	0.81	0.69	1.27	1.44	1.87	2.42	2.59	2.68	6.25	6.61	5.79	6.63	2.62	1.47	1.04
EBITDA	1.83B	2.15B	1.44B	1.28B	1.8B	516.39M	615.67M	755.95M	425.3M	1.11B	1.16B	1.37B	1.38B	1.69B	1.9B	1.56B	1.69B	2.64B	2.66B	2.58B	2.65B	1.31B	771.09M	437.5M
EBIT	1.56B	1.92B	1.22B	1.37B	1.89B	559.43M	583.53M	563.04M	226.72M	889.72M	1B	1.37B	1.38B	1.68B	1.89B	1.55B	1.49B	2.59B	2.59B	2.43B	2.73B	1.22B	711.3M	463.36M
Depreciation & Amortization	1.43B	1.43B	1.29B	734.03M	5.67M	77.92M	76.48M	235.84M	240.09M	172.43M	178.24M	23.2M	23.2M	23.2M	23.4M	23.4M	23.47M	23.26M	23.06M	23.06M	23.92M	18.13M	12.33M	6.6M